These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25882790)
1. A phosphorescent rhenium(I) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction. Ye RR; Tan CP; Lin YN; Ji LN; Mao ZW Chem Commun (Camb); 2015 May; 51(39):8353-6. PubMed ID: 25882790 [TBL] [Abstract][Full Text] [Related]
2. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019 [TBL] [Abstract][Full Text] [Related]
3. Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate. Yang J; Cao Q; Zhang H; Hao L; Zhou D; Gan Z; Li Z; Tong YX; Ji LN; Mao ZW Biomaterials; 2018 Sep; 176():94-105. PubMed ID: 29870900 [TBL] [Abstract][Full Text] [Related]
4. Recoding the Cancer Epigenome by Intervening in Metabolism and Iron Homeostasis with Mitochondria-Targeted Rhenium(I) Complexes. Pan ZY; Tan CP; Rao LS; Zhang H; Zheng Y; Hao L; Ji LN; Mao ZW Angew Chem Int Ed Engl; 2020 Oct; 59(42):18755-18762. PubMed ID: 32634290 [TBL] [Abstract][Full Text] [Related]
5. Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction. Ye RR; Chen BC; Lu JJ; Ma XR; Li RT J Inorg Biochem; 2021 Oct; 223():111537. PubMed ID: 34273716 [TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted Re(I) complexes bearing guanidinium as ligands and their anticancer activity. He SF; Pan NL; Chen BB; Liao JX; Huang MY; Qiu HJ; Jiang DC; Wang JJ; Chen JX; Sun J J Biol Inorg Chem; 2020 Dec; 25(8):1107-1116. PubMed ID: 33079244 [TBL] [Abstract][Full Text] [Related]
7. A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO). Piccinonna S; Margiotta N; Denora N; Iacobazzi RM; Pacifico C; Trapani G; Natile G Dalton Trans; 2013 Jul; 42(28):10112-5. PubMed ID: 23752769 [TBL] [Abstract][Full Text] [Related]
8. Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms. Ye RR; Tan CP; Chen MH; Hao L; Ji LN; Mao ZW Chemistry; 2016 Jun; 22(23):7800-9. PubMed ID: 27106876 [TBL] [Abstract][Full Text] [Related]
9. Rhenium tetrazolato complexes coordinated to thioalkyl-functionalised phenanthroline ligands: synthesis, photophysical characterisation, and incubation in live HeLa cells. Werrett MV; Wright PJ; Simpson PV; Raiteri P; Skelton BW; Stagni S; Buckley AG; Rigby PJ; Massi M Dalton Trans; 2015 Dec; 44(47):20636-47. PubMed ID: 26563409 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors. Luo Y; Liu HM; Su MB; Sheng L; Zhou YB; Li J; Lu W Bioorg Med Chem Lett; 2011 Aug; 21(16):4844-6. PubMed ID: 21745740 [TBL] [Abstract][Full Text] [Related]
11. (2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors. Vaisburg A; Bernstein N; Frechette S; Allan M; Abou-Khalil E; Leit S; Moradei O; Bouchain G; Wang J; Woo SH; Fournel M; Yan PT; Trachy-Bourget MC; Kalita A; Beaulieu C; Li Z; MacLeod AR; Besterman JM; Delorme D Bioorg Med Chem Lett; 2004 Jan; 14(1):283-7. PubMed ID: 14684344 [TBL] [Abstract][Full Text] [Related]
12. Luminescent rhenium(I) polypyridine fluorous complexes as novel trifunctional biological probes. Louie MW; Fong TT; Lo KK Inorg Chem; 2011 Oct; 50(19):9465-71. PubMed ID: 21894912 [TBL] [Abstract][Full Text] [Related]
13. [A new target of cancer therapy: advances in the study of histone deacetylase]. Liu AL; Long J; Wang N; Du GH Yao Xue Xue Bao; 2005 Jul; 40(7):585-90. PubMed ID: 16196262 [No Abstract] [Full Text] [Related]
14. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters. Xargay-Torrent S; López-Guerra M; Saborit-Villarroya I; Rosich L; Campo E; Roué G; Colomer D Clin Cancer Res; 2011 Jun; 17(12):3956-68. PubMed ID: 21652541 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors in cancer therapy. Fouladi M Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962 [No Abstract] [Full Text] [Related]
16. Histone deacetylase inhibitors: a novel class of anti-cancer agents on its way to the market. Körner M; Tibes U Prog Med Chem; 2008; 46():205-80. PubMed ID: 18381127 [No Abstract] [Full Text] [Related]
17. Synthesis and biochemical analysis of 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoro-N-hydroxy-octanediamides as inhibitors of human histone deacetylases. Henkes LM; Haus P; Jäger F; Ludwig J; Meyer-Almes FJ Bioorg Med Chem; 2012 Jan; 20(2):985-95. PubMed ID: 22182579 [TBL] [Abstract][Full Text] [Related]
18. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects. Liao V; Liu T; Codd R Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316 [TBL] [Abstract][Full Text] [Related]